tradingkey.logo
搜索

Advanced Biomed Inc

ADVB
添加自选
10.875USD
-3.485-24.27%
收盘 07-28 16:00美东报价延迟15分钟
15.03M总市值
0.21市盈率 TTM

关于 Advanced Biomed Inc 公司

Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Advanced Biomed Inc简介

公司代码ADVB
公司名称Advanced Biomed Inc
上市日期Mar 06, 2025
CEO- -
员工数量31
证券类型Ordinary Share
年结日Mar 06
公司地址401 Ryland St
城市RENO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编89502
电话1862120510823
网址http://www.advanbiomed.com/
公司代码ADVB
上市日期Mar 06, 2025
CEO- -

Advanced Biomed Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
名称
名称/职务
职务
持股
持股变动
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--

常见问题

Advanced Biomed Inc的前五大股东是谁?

Advanced Biomed Inc 的前五大股东如下:Dr. I-Fang (Steven) Cheng, Ph.D.

有多少机构持有Advanced Biomed Inc(ADVB)的股份?

截至2026Q1,共有6家机构持有Advanced Biomed Inc的股份,合计持有的股份价值约为1.99K,占公司总股份的0.12%。与2025Q4相比,机构持股有所增加,增幅为-12429.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有